Intezyne
Latest round
- Series A
Last raised
- Oct 2017
Total raised
- $10M
Investors
- 1
About Intezyne
Intezyne, Inc.Intezyne, Inc. was founded in 2004 in Tampa, US, focusing on advanced cancer treatment solutions.Intezyne is focused on the development of advanced cancer therapies, particularly through its unique platform that leverages proprietary technology for targeted drug delivery. The company's core product offerings are designed to enhance the efficacy of existing cancer treatments while minimizing side effects. This is achieved through innovative formulations that allow for more precise targeting of cancer cells, which is critical in addressing various types of malignancies. Intezyne primarily serves oncology clinics, hospitals, and research institutions, which utilize these therapies in both clinical and experimental settings.Intezyne's revenue model is structured around partnerships with healthcare providers and institutions that aim to integrate their therapies into clinical practice. Transactions typically occur through B2B agreements, where the firm collaborates with hospitals and oncology centers to supply its specialized cancer therapies. These partnerships are often established through licensing agreements and collaborations for clinical trials, allowing for a streamlined introduction of their products into the market. The company focuses on securing contracts that ensure a steady flow of revenue as their therapies progress through various stages of clinical development. The company is also strategizing to expand its market presence in Europe and select regions in Asia by the end of 2025, capitalizing on the growing demand for targeted cancer therapies.
Who invested in Intezyne
1 investor across 1 round
See all investors in Intezyne
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 6, 2017
Amount
$10M
Investors
Questions about Intezyne
Who invested in Intezyne?
Intezyne has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Intezyne raised?
Intezyne has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Intezyne last raise money?
Intezyne's most recent round on record is a Series A, in Oct 2017.
What does Intezyne do?
Intezyne is a pharmaceuticals company.
Where is Intezyne headquartered?
Intezyne is headquartered in Tampa, US.
Which VCs invest in companies like Intezyne?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Intezyne's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Intezyne? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.